Special Issue "Antibody Constructs"


A special issue of Antibodies (ISSN 2073-4468).

Deadline for manuscript submissions: 30 November 2014

Special Issue Editors

Guest Editor
Dr. Satoshi Ohtake
Pharmaceutical R&D, BioTherapeutics Pharmaceutical Sciences, Pfizer Inc., 700 Chesterfield Parkway West, Chesterfield, MO 63017, USA
Website: http://www.pfizer.com
E-Mail: Satoshi.Ohtake@pfizer.com
Interests: formulation and manufacturing of biologics; novel biotherapeutic modalities; drying technologies; solid state stabilization; vaccines

Guest Editor
Dr. Tsutomu Arakawa
Alliance Protein Laboratories, 6042 Cornerstone Ct West, Suite A1, San Diego, CA 92121, USA
Website: http://www.ap-lab.com/people.htm
E-Mail: Tarakawa2@aol.com
Interests: modulation of aqueous protein solution by solvents

Special Issue Information

Dear Colleagues,

Antibody fragments are under development as a next generation antibody therapeutic that takes advantage of their smaller sizes in comparison to a full antibody. They have unique structural characteristics, and hence challenges, which may differ from those of full antibodies in regard to production, purification/refolding, and formulation. The current Special Issue welcomes contributions from experts in the field that address and review the current state-of-the art technology and developments in the field of antibody fragments.

Dr. Satoshi Ohtake
Dr. Tsutomu Arakawa
Guest Editors


Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibodies is an international peer-reviewed Open Access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 300 CHF (Swiss Francs). English correction and/or formatting fees of 250 CHF (Swiss Francs) will be charged in certain cases for those articles accepted for publication that require extensive additional formatting and/or English corrections.


  • antibody
  • antibody fragments
  • expression
  • purification
  • refolding
  • formulation

Published Papers (4 papers)

Antibodies 2014, 3(1), 155-168; doi:10.3390/antib3010155
Received: 28 January 2014; in revised form: 18 February 2014 / Accepted: 24 February 2014 / Published: 12 March 2014
Show/Hide Abstract | PDF Full-text (302 KB) | HTML Full-text | XML Full-text

by , ,  and
Antibodies 2014, 3(2), 182-191; doi:10.3390/antib3020182
Received: 11 February 2014; in revised form: 18 March 2014 / Accepted: 20 March 2014 / Published: 2 April 2014
Show/Hide Abstract | PDF Full-text (645 KB) | HTML Full-text | XML Full-text

by  and
Antibodies 2014, 3(2), 232-241; doi:10.3390/antib3020232
Received: 20 January 2014; in revised form: 26 April 2014 / Accepted: 13 May 2014 / Published: 23 May 2014
Show/Hide Abstract | PDF Full-text (343 KB) | HTML Full-text | XML Full-text

by ,  and
Antibodies 2014, 3(2), 242-252; doi:10.3390/antib3020242
Received: 13 March 2014; in revised form: 2 May 2014 / Accepted: 12 May 2014 / Published: 26 May 2014
Show/Hide Abstract | PDF Full-text (550 KB) | HTML Full-text | XML Full-text

Last update: 23 May 2014

Antibodies EISSN 2073-4468 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert